ACE-Neuro: A tailored exercise oncology program for neuro-oncology patients – Study protocol

Contemporary Clinical Trials Communications

Lauren C. Capozzi¹  Meghan H. McDonough²  Jessica Danyluk³  Paula A. Ospina⁴  Emma McLaughlin⁵  George J. Francis⁶  Jacob C. Easaw⁷  Tanya Williamson⁸  Christine Lesiuk⁸  Amy Driga⁹  Marie de Guzman Wilding⁹  Margaret L. McNeely⁹  Lori Radke⁹  Julia T. Daun⁹  Gloria Roldan Urgoiti⁹  S. Nicole Culos-Reed^1,10 

[1] Corresponding author. University of Calgary, Faculty of Kinesiology, 2500 University Drive NW, Calgary, Alberta, T2N 1N4, Canada.;Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, AB, Canada;Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada;Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, AB, Canada;Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB, Canada;Department of Medical Oncology, Tom Baker Cancer Centre, Alberta Health Services, Calgary, AB, Canada;Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada;Faculty of Kinesiology, University of Calgary, Calgary, AB, Canada;Supportive Care: Rehabilitation Oncology, Cancer Care Alberta, Alberta Health Services, AB, Canada;

关键词: Neuro-Oncology;    Brain Tumour;    Exercise;    Intervention;    Feasibility;    Implementation;   

DOI  :  

来源: DOAJ

【 摘 要 】

Background: Patients with primary brain tumours (i.e., neuro-oncology patients) lack access to exercise oncology and wellness resources. The purpose of the Alberta Cancer Exercise – Neuro-Oncology (ACE-Neuro) study is to assess the feasibility of a tailored neuro-oncology exercise program for patients across Alberta, Canada. The primary outcome is to assess the feasibility of ACE-Neuro. The secondary outcome is to examine preliminary effectiveness of ACE-Neuro on patient-reported outcomes and functional fitness. Methods: Neuro-oncology patients with a malignant or benign primary brain tumour that are pre, on, or completed treatment, are >18 years, and able to consent in English are eligible to participate in the study. Following referral from the clinical team to cancer rehabilitation and the study team, participants are triaged to determine their appropriateness for ACE-Neuro and other cancer rehabilitation services (including physiatry, physiotherapy, occupational therapy, and exercise physiology). In ACE-Neuro, participants complete a tailored 12-week exercise program with pre-post assessments of patient-reported outcomes and functional fitness, and objective physical activity tracked across the 12-week program. ACE-Neuro includes individual and group-based exercise sessions, as well as health coaching. Conclusion: We are supporting ACE-Neuro implementation into clinical cancer care, with assessment of needs enabling a tailored exercise prescription.

【 授权许可】

Unknown